Sexual side-effects of contemporary antidepressants: review (Q34996668)

5 August 2017

1 reference

title

Sexual side-effects of contemporary antidepressants: review (English)

1 reference

5 August 2017

Isaac Schweitzer

1 reference

5 August 2017

Kay Maguire

series ordinal

1 reference

5 August 2017

Chee Ng

series ordinal

1 reference

5 August 2017

publication date

1 September 2009

1 reference

Australian and New Zealand Journal of Psychiatry

5 August 2017

published in

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

795-808

1 reference

Sexual dysfunction associated with antidepressant therapy

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Antidepressants and sexual dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Tolerability and safety of fluvoxamine and other antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Depression and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

Citalopram-associated clitoral priapism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048670903107575

10.1080/00048670903107575

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference